Jarlego, Cliff S.
HRN: 23 23 12 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/29/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/29/2023
07/05/2023
IV
1.5gm
Q6
Acute Tonsillopharyngitis
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes